250mg Geftinat Gefitinib Tablets (2) About
Experience an invincible option in targeted therapy with the new 250mg Geftinat Gefitinib Tablets (2). Now available at a compelling price cut, these astounding, customizable tablets are expertly crafted by Natco Pharma, India, and are supplied in boxes of 30 round, white, film-coated tablets. Ideal for the treatment of pancreatic cancer, Geftinat boasts a crackerjack salt composition of Gefitinib, ensuring advanced oral anticancer application. Each prescription-required dose comes with a 24-month shelf life. As trusted exporters, suppliers, and traders from India, we guarantee premium quality, secure packaging, and customizable options for global buyers.
Versatile Application for Oncology Needs
250mg Geftinat Gefitinib Tablets (2) are specifically indicated for the treatment of pancreatic cancer, offering targeted therapy for affected individuals. Suitable for hospital oncology units, specialty cancer care centers, and doctor's clinics, these tablets provide both specific and general use in cancer treatment regimens. Their customizable dosing nature ensures astute adaptation to patient needs, delivering remarkable therapeutic value for healthcare professionals and patients alike.
Reliable Shipping and Certification Assurance
FOB Port delivery for 250mg Geftinat Gefitinib Tablets (2) ensures seamless logistics for international buyers. Shipped goods are dispatched promptly upon receipt of a valid Purchase Order, with comprehensive documentation. Our products hold necessary certifications, supporting compliance with global pharmaceutical standards. Delivery times are typically swift, courtesy of our adept logistic partners, ensuring medicines reach your destination efficiently, no matter the location.
FAQ's of 250mg Geftinat Gefitinib Tablets (2):
Q: How should 250mg Geftinat Gefitinib Tablets (2) be used for optimal benefit?
A: 250mg Geftinat Gefitinib Tablets (2) should be used strictly as prescribed by a healthcare professional, ideally at the same time each day. Swallow the film-coated tablet whole, with or without food, to ensure effective absorption and targeted cancer therapy.
Q: What is the primary indication for Geftinat Gefitinib Tablets (2)?
A: The primary indication for 250mg Geftinat Gefitinib Tablets (2) is the treatment of pancreatic cancer. They act as a targeted therapy, blocking cancer cell growth and spread to improve patient outcomes.
Q: When can I expect delivery after placing a purchase order?
A: Once a purchase order is received, the shipment process begins promptly. Delivery times vary depending on the destination but are generally swift due to our robust logistics and efficient FOB Port handling.
Q: Where are these tablets manufactured and what certifications support their quality?
A: 250mg Geftinat Gefitinib Tablets (2) are manufactured in India by Natco Pharma, a globally recognized producer. The product comes with all relevant pharmaceutical industry certifications suitable for export and adherence to international quality standards.
Q: What storage conditions are required for maintaining tablet efficacy?
A: These tablets should be stored below 30C in a dry place, away from direct sunlight and moisture, ensuring their effectiveness throughout the 24-month shelf life.
Send Inquiry
